ASKA Pharmaceutical Holdings Co.,Ltd.
TSE:4886.T
2187 (JPY) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 16,738 | 14,505 | 12,103 | 10,514 | 7,294 | 11,107 | 10,346 | 14,761 | 5,462 | 6,724 | 4,269 | 3,983 |
Short Term Investments
| 500 | 3,400 | 5,000 | 0 | 0 | 0 | 1,000 | 0 | 0 | 2,850 | 2,650 | 2,694 |
Cash and Short Term Investments
| 17,238 | 17,905 | 17,103 | 10,514 | 7,294 | 11,107 | 10,346 | 14,761 | 5,462 | 9,574 | 6,919 | 6,677 |
Net Receivables
| 15,579 | 15,217 | 14,482 | 13,153 | 13,792 | 11,022 | 10,400 | 9,485 | 8,566 | 8,469 | 7,442 | 9,277 |
Inventory
| 20,402 | 17,687 | 15,060 | 14,372 | 14,042 | 14,005 | 11,868 | 10,683 | 11,125 | 11,375 | 9,231 | 9,569 |
Other Current Assets
| 2,924 | 2,950 | 2,912 | 1,893 | 2,198 | 1,695 | 2,204 | 2,130 | 1,725 | 2,772 | 2,523 | 1,710 |
Total Current Assets
| 56,143 | 53,759 | 49,557 | 39,932 | 37,326 | 37,829 | 34,818 | 37,059 | 26,878 | 32,190 | 26,115 | 27,233 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 11,263 | 10,796 | 10,936 | 12,675 | 13,539 | 13,573 | 12,129 | 12,829 | 13,801 | 13,103 | 12,400 | 11,889 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 2,877 | 4,465 | 6,183 | 11,893 | 13,584 | 15,332 | 3,334 | 3,491 | 3,296 | 543 | 695 | 1,373 |
Goodwill and Intangible Assets
| 2,877 | 4,465 | 6,183 | 11,893 | 13,584 | 15,332 | 3,334 | 3,491 | 3,296 | 543 | 695 | 1,373 |
Long Term Investments
| 15,654 | 16,400 | 7,223 | 12,503 | 9,794 | 11,052 | 11,747 | 10,490 | 8,962 | 12,204 | 10,258 | 9,290 |
Tax Assets
| 5,263 | 1,717 | 2,376 | 3,513 | 3,670 | 2,578 | 2,111 | 1,508 | 1,393 | 0 | 0 | 0 |
Other Non-Current Assets
| 2,112 | -1 | 7,020 | 2,066 | 2,326 | 1,830 | 2,096 | 749 | 3,148 | 893 | 1,801 | 1,985 |
Total Non-Current Assets
| 37,169 | 33,377 | 33,738 | 42,650 | 42,913 | 44,365 | 31,417 | 29,067 | 30,600 | 26,743 | 25,154 | 24,537 |
Total Assets
| 93,312 | 87,138 | 83,297 | 82,582 | 80,239 | 82,194 | 66,235 | 66,126 | 57,478 | 58,933 | 51,269 | 51,770 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 7,355 | 2,838 | 3,118 | 6,455 | 6,040 | 7,107 | 5,217 | 5,309 | 3,784 | 6,856 | 4,074 | 4,313 |
Short Term Debt
| 4,980 | 3,438 | 1,723 | 2,648 | 2,748 | 3,498 | 1,200 | 1,200 | 2,458 | 808 | 1,441 | 608 |
Tax Payables
| 2,896 | 736 | 0 | 936 | 0 | 0 | 0 | 1,570 | 81 | 0 | 0 | 0 |
Deferred Revenue
| 177 | 6,113 | 6,055 | 936 | 0 | 0 | 0 | 1,570 | 81 | 0 | 0 | 0 |
Other Current Liabilities
| 11,456 | 5,261 | 5,115 | 6,698 | 8,339 | 7,397 | 7,797 | 8,174 | 4,669 | 7,210 | 3,714 | 4,987 |
Total Current Liabilities
| 23,968 | 17,650 | 16,011 | 16,737 | 17,127 | 18,002 | 14,214 | 16,253 | 10,992 | 14,874 | 9,229 | 9,908 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 4,505 | 9,185 | 12,323 | 13,747 | 13,671 | 12,970 | 1,750 | 2,500 | 3,250 | 558 | 116 | 1,174 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 2,567 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 341 | 5,772 | 6,072 | 7,587 | 7,865 | 7,765 | 7,710 | 7,860 | 7,275 | 6,925 | 7,984 | 7,339 |
Total Non-Current Liabilities
| 7,413 | 14,957 | 18,395 | 21,334 | 21,536 | 20,735 | 9,460 | 10,360 | 10,525 | 7,483 | 8,100 | 8,513 |
Total Liabilities
| 31,381 | 32,607 | 34,406 | 38,071 | 38,663 | 38,737 | 23,674 | 26,613 | 21,517 | 22,357 | 17,329 | 18,421 |
Equity: | ||||||||||||
Preferred Stock
| 0 | 49,314 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 1,197 | 1,197 | 1,197 | 1,197 | 1,197 | 1,197 | 1,197 | 1,197 | 1,197 | 1,197 | 1,197 | 1,197 |
Retained Earnings
| 56,372 | 49,619 | 45,833 | 41,790 | 39,560 | 40,630 | 39,280 | 37,312 | 34,761 | 34,447 | 33,107 | 33,000 |
Accumulated Other Comprehensive Income/Loss
| 5,798 | 5,217 | 3,472 | 2,733 | 2,079 | 2,995 | 3,508 | 2,546 | 1,562 | 2,551 | 1,243 | 827 |
Other Total Stockholders Equity
| -1,437 | -50,816 | -1,611 | -1,210 | -1,263 | -1,366 | -1,426 | -1,544 | -1,559 | -1,619 | -1,642 | -1,680 |
Total Shareholders Equity
| 61,930 | 54,531 | 48,891 | 44,510 | 41,573 | 43,456 | 42,559 | 39,511 | 35,961 | 36,576 | 33,905 | 33,344 |
Total Equity
| 61,930 | 54,531 | 48,891 | 44,510 | 41,573 | 43,456 | 42,559 | 39,511 | 35,961 | 36,576 | 33,940 | 33,349 |
Total Liabilities & Shareholders Equity
| 93,311 | 87,138 | 83,297 | 82,582 | 80,236 | 82,193 | 66,233 | 66,124 | 57,478 | 58,933 | 51,269 | 51,770 |